Neurologic disorders tied to increased risk for in-hospital mortality
Inactivated SARS-CoV-2 Vaccine Well Tolerated in Phase 1/2 Trial
Neutralizing antibody geometric mean titers higher in vaccine group at day 42 in phase 1 trial
COVID-19-Linked Deaths Mainly in Seniors in May to August 2020
Percentage of decedents who were Hispanic increased from 16.3 to 26.4 percent in May to August
No Pfizer COVID-19 Vaccine Expected Before Election
Company has reversed its previous claims that it would apply for the approval in October
Emergency Sick Leave Helped to Flatten the U.S. COVID-19 Curve
Compared with before sick leave, newly gained sick leave led to 400 fewer confirmed cases per day
No Evidence Found of Vertical Transmission of SARS-CoV-2
Newborns of mothers with severe/critical COVID-19 born early, at risk for needing phototherapy
Time to Results Faster With Point-of-Care COVID-19 Testing
Time to results significantly shorter with QIAstat-Dx Respiratory SARS-CoV-2 Panel than with PCR
NIH Launches Trial of Antibody Drugs Against COVID-19
The phase 2 trial will assess effectiveness of monoclonal antibodies in conjunction with remdesivir
Sitagliptin May Cut Mortality in T2DM Patients With COVID-19
Sitagliptin at time of hospitalization linked to reduced mortality, improved clinical outcomes
Black Race Tied to COVID-19 Admissions, but Not Deaths
In-hospital mortality higher for Asian patients, despite lower risk for hospital admission